Vimarsana
Biggest News Aggregation in the World

Exclusive Partner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exclusive Partner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exclusive Partner Today - Breaking & Trending Today

Summit ignites global collaboration in research, innovation - Vimarsana News

Summit ignites global collaboration in research, innovation

Doha, Qatar:The Web Summit Qatar has provided the platform to showcase Qatar s opportunities in research and innovation to the world, said an industry...

QRDI council announces Web Summit agenda - Vimarsana News

QRDI council announces Web Summit agenda

QRDI council announces Web Summit agenda 

Sri Lankan Innovators Shine at APICTA 2023: Celebrating Outstanding Achievements in Technology - Adaderana Biz English - Vimarsana News

Sri Lankan Innovators Shine at APICTA 2023: Celebrating Outstanding Achievements in Technology - Adaderana Biz English

The Asia Pacific ICT Alliance (APICTA) Awards 2023, held in Hong Kong, witnessed a remarkable showcase of talent from across the region. Among the distinguished winners were nominees from Sri Lanka, selected through the National ICT Awards (NBQSA) 2023 organized by BCS Sri Lanka Section and the Young Computer Scientist (YCS) competition conducted by FITIS....

Sri Lankan innovators shine at APICTA 2023 - Vimarsana News

Sri Lankan innovators shine at APICTA 2023

Latest news, analysis and opinions from the Daily FT, Sri Lanka's only national business newspaper. ..

Source: ft.lk
Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics' ARCT-154, the first Self-Amplifying mRNA vaccine approved for COVID in adults - Vimarsana News

Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics' ARCT-154, the first Self-Amplifying mRNA vaccine approved for COVID in adults

Exclusive Partner in Japan, Meiji Seika Pharma advances regulatory approval This historic approval of the world's first Self-Amplifying messenger RNA COVID-19 Vaccine underscores CSL's promise to...